Both in Pharmaceuticals
United Therapeutics vs Alnylam Pharmaceuticals
Over the past year UTHR returned +34.4% and ALNY returned −63.8%; their daily moves had a correlation of 0.02.
UTHR +34.4% ALNY −63.8%Growth of $1, one year, split-adjusted
| Metric | UTHR | ALNY |
|---|---|---|
| Price | $598.72 | $165.00 |
| Market cap | $25.68B | $22.10B |
| Today | +0.87% | −5.17% |
| 1 month | +4.8% | −28.6% |
| 6 months | +5.0% | −44.3% |
| Year to date | +22.9% | −58.5% |
| 1 year | +31.5% | −65.7% |
| Revenue growth (YoY) | −1.9% | +16.7% |
| Gross margin | 87.3% | 75.2% |
| Net margin | 42.5% | 148.6% |
| P/E (TTM) | 19.6× | 8.1× |
| Price / sales | 8.1× | 4.4× |
| Net cash | $2.66B | $2.57B |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 72.5% |
| Short % of float | 5.9% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).